ENSAYO PARA LA DETERMINACIÓN SEMICUANTITATIVA DE AUTOANTICUERPOS ESPECÍFICOS DE CLASE IGG FRENTE AL PÉPTIDO CÍCLICO CITRULINADO (CCP)
Mexico·Clase I·III. Agentes de
diagnóstico·ABBOTT LABORATORIES
DE MÉXICO, S.A. DE C.V.·Registered March 25, 2024- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- ANTI-CCP.
- Trade Name (English)
- ANTI-CCP.
- Analysis ID
- 0830R2024 SSA
- Registration Date
- March 25, 2024
- Name (Spanish)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
- Name (English)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for ENSAYO PARA LA DETERMINACIÓN SEMICUANTITATIVA DE AUTOANTICUERPOS ESPECÍFICOS DE CLASE IGG FRENTE AL PÉPTIDO CÍCLICO CITRULINADO (CCP) (ENSAYO PARA LA DETERMINACIÓN SEMICUANTITATIVA DE AUTOANTICUERPOS ESPECÍFICOS DE CLASE IGG FRENTE AL PÉPTIDO CÍCLICO CITRULINADO (CCP)) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 0830R2024 SSA and manufactured by ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.. The device was registered on March 25, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.